<DOC>
	<DOCNO>NCT00840294</DOCNO>
	<brief_summary>The purpose study assess impact empiric course antibiotic men elevate prostate-specific antigen ( PSA ) level .</brief_summary>
	<brief_title>Randomized Trial Ciprofloxacin Versus Observation Men With Elevated Prostate Specific Antigen ( PSA )</brief_title>
	<detailed_description>Study Objectives : Primary Objective : To assess impact ciprofloxacin change PSA baseline/randomization prostate biopsy Secondary Objective : To assess impact ciprofloxacin overall infectious complication follow prostate biopsy The impact observation versus ciprofloxacin PSA level assess PSA change baseline . The first PSA measurement study entry randomization . The second PSA measurement immediately prior prostate biopsy , occur 21-45 day follow randomization .</detailed_description>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Men 18 yr . old An elevate PSA ( &gt; 2.5 ng/ml ) normal digital rectal exam Have elect proceed diagnostic 12core prostate biopsy Previous prostate biopsy History prostate cancer Urinary tract infection prostatitis within one year study entry antibiotic use within one month prior PSA level pyuria bacteruria urinalysis allergy fluoroquinolones</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Men Elevated PSA</keyword>
</DOC>